Bristol Myers Squibb Co
BMY
Revenue
11.89B
▼-309.00M▼-2.53%
3 Months ChangeAssets
93.67B
▼-976.00M▼-1.03%
3 Months ChangeLiabilities
76.47B
▼-1.11B▼-1.43%
3 Months ChangeFree Cash Flow
2.55B
▼-142.00M▼-5.27%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 10-Q
ID: 0000014272-24-000147
2024-10-31
Form 8-K
ID: 0000014272-24-000145
2024-07-26
Form 10-Q
ID: 0000014272-24-000123
2024-07-26
Form 8-K
ID: 0000014272-24-000121
2024-06-18
Form 8-K
ID: 0001140361-24-030533
2024-05-09
Form 8-K
ID: 0001140361-24-025213
2024-04-25
Form 10-Q
ID: 0000014272-24-000096
2024-04-25
Form 8-K
ID: 0000014272-24-000094
2024-03-18
Form 8-K
ID: 0001140361-24-013978
2024-03-18
Form 8-K
ID: 0001140361-24-013726